Annotation Detail for B3GNT2

Basic Information
Top
Gene Symbol: | B3GNT2 ( B3GN-T2,B3GNT,B3GNT-2,B3GNT1,BETA3GNT,BGNT2,BGnT-2 ) |
---|
Gene Full Name: | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
---|
Band: | 2p15 |
---|
Quick Links | Entrez ID:10678; OMIM: 605581; Uniprot ID:B3GN2_HUMAN; ENSEMBL ID: ENSG00000170340; HGNC ID: 15629 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series |
hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate |
hsa01100 | Metabolic pathways |
Desease ID | Desease Name |
---|
1848 | Embryoma |
2106 | Pancreas cancer |
Desease Name |
---|
Ankylosing spondylitis |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of B3GNT2 mRNA | decreases expression | 16788091
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in increased expression of B3GNT2 mRNA | increases expression | 16849584
|
D007632 |
Keratan Sulfate |
B3GNT2 protein results in increased chemical synthesis of Keratan Sulfate | increases chemical synthesis | 12218059
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of B3GNT2 mRNA | decreases expression | 16788091
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.94 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.30 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.33 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.43 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.91 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
4.03 | 16206674 16197459 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.23 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.22 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.88 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.37 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.30 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.22 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.88 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.80 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.26 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 10589399 9224671 9125849 9142499 14991402 16925845 17551590 9211117 9664655 8800419 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.19 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.35 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.87 | 16938888 9664655 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.07 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.24 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.44 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.88 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.07 | 14991402 9664655 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.53 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.13 | 16778211 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.33 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.33 | 15992940 17551590 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.93 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.12 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.39 | 16140955 19075265 19029980 16823087 17217047 17361223 19225113 17649720 12679006 17294898 17506722 16935935 9834237 17301526 17368321 16891316 19642359 17339181 16766008 17712046 19035177 15748426 16788101 17107899 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.58 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.91 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.98 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.99 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.28 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.57 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.28 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.29 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.44 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.24 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.57 | 15976015 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.07 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.42 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.56 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.76 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.33 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.18 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.45 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.07 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.33 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.56 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.34 | 16287080 |
Pathway ID |
Pathway Name |
---|
KEGG:00533 |
Glycosaminoglycan biosynthesis - keratan sulfate |
KEGG:00601 |
Glycosphingolipid biosynthesis - lacto and neolacto series |
KEGG:01100 |
Metabolic pathways |
KEGG:00512 |
Mucin type O-Glycan biosynthesis |
PharmGKB Accession:PA25218
Releated gene ID |
Related gene Name |
PA25218 | B3GNT2 |